These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 19949302)

  • 1. RNAi-induced synthetic lethality in cancer therapy.
    Dai B; Fang B; Roth JA
    Cancer Biol Ther; 2009 Dec; 8(23):2314-6. PubMed ID: 19949302
    [No Abstract]   [Full Text] [Related]  

  • 2. Induction of in vivo synthetic lethal RNAi responses to treat glioblastoma.
    Michiue H; Eguchi A; Scadeng M; Dowdy SF
    Cancer Biol Ther; 2009 Dec; 8(23):2306-13. PubMed ID: 19901546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current views on inducing synthetic lethal RNAi responses in the treatment of cancer.
    Kacsinta AD; Dowdy SF
    Expert Opin Biol Ther; 2016; 16(2):161-72. PubMed ID: 26630128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Boosting RNAi therapy for orthotopic glioblastoma with nontoxic brain-targeting chimaeric polymersomes.
    Shi Y; Jiang Y; Cao J; Yang W; Zhang J; Meng F; Zhong Z
    J Control Release; 2018 Dec; 292():163-171. PubMed ID: 30408555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. shRNA-mediated RNA interference as a tool for genetic synthetic lethality screening in mouse embryo fibroblasts.
    Einav Y; Agami R; Canaani D
    FEBS Lett; 2005 Jan; 579(1):199-202. PubMed ID: 15620713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Connectivity Homology Enables Inter-Species Network Models of Synthetic Lethality.
    Jacunski A; Dixon SJ; Tatonetti NP
    PLoS Comput Biol; 2015 Oct; 11(10):e1004506. PubMed ID: 26451775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient RNA delivery by integrin-targeted glutathione responsive polyethyleneimine capped gold nanorods.
    Wang F; Zhang W; Shen Y; Huang Q; Zhou D; Guo S
    Acta Biomater; 2015 Sep; 23():136-146. PubMed ID: 26026304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. H
    Zhou M; Jiang N; Fan J; Fu S; Luo H; Su P; Zhang M; Shi H; Zeng J; Huang Y; Li Y; Shen H; Zhang A; Li R
    J Control Release; 2019 Sep; 310():24-35. PubMed ID: 31404556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T7 peptide-functionalized nanoparticles utilizing RNA interference for glioma dual targeting.
    Kuang Y; An S; Guo Y; Huang S; Shao K; Liu Y; Li J; Ma H; Jiang C
    Int J Pharm; 2013 Sep; 454(1):11-20. PubMed ID: 23867728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ShRNA-based POLD2 expression knockdown sensitizes glioblastoma to DNA-Damaging therapeutics.
    Xu Q; Hu C; Zhu Y; Wang K; Lal B; Li L; Tang J; Wei S; Huang G; Xia S; Lv S; Laterra J; Jiang Y; Li Y
    Cancer Lett; 2020 Jul; 482():126-135. PubMed ID: 31954770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNAi based approaches to the treatment of malignant glioma.
    Mathupala SP; Guthikonda M; Sloan AE
    Technol Cancer Res Treat; 2006 Jun; 5(3):261-9. PubMed ID: 16700622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic lethal screen identification of chemosensitizer loci in cancer cells.
    Whitehurst AW; Bodemann BO; Cardenas J; Ferguson D; Girard L; Peyton M; Minna JD; Michnoff C; Hao W; Roth MG; Xie XJ; White MA
    Nature; 2007 Apr; 446(7137):815-9. PubMed ID: 17429401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting cancer cells by synthetic lethality: autophagy and VHL in cancer therapeutics.
    Chan DA; Giaccia AJ
    Cell Cycle; 2008 Oct; 7(19):2987-90. PubMed ID: 18818511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of glioma growth by a GOLPH3 siRNA-loaded cationic liposomes.
    Yuan Z; Zhao L; Zhang Y; Li S; Pan B; Hua L; Wang Z; Ye C; Lu J; Yu R; Liu H
    J Neurooncol; 2018 Nov; 140(2):249-260. PubMed ID: 30105446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA interference and nonviral targeted gene therapy of experimental brain cancer.
    Boado RJ
    NeuroRx; 2005 Jan; 2(1):139-50. PubMed ID: 15717065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA interference therapy for glioblastoma.
    Guo D; Wang B; Han F; Lei T
    Expert Opin Biol Ther; 2010 Jun; 10(6):927-36. PubMed ID: 20415602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic synthetic lethality approaches in cancer therapy.
    Yang H; Cui W; Wang L
    Clin Epigenetics; 2019 Oct; 11(1):136. PubMed ID: 31590683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Synthetic lethality as a functional tool in basic research and in anticancer therapy].
    Toma M; Skorski T; Sliwiński T
    Postepy Hig Med Dosw (Online); 2014 Sep; 68():1091-103. PubMed ID: 25228518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous siRNA of brain cancer with receptor targeting and avidin-biotin technology.
    Xia CF; Zhang Y; Zhang Y; Boado RJ; Pardridge WM
    Pharm Res; 2007 Dec; 24(12):2309-16. PubMed ID: 17926121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivery of Small Interfering RNA to Inhibit Vascular Endothelial Growth Factor in Zebrafish Using Natural Brain Endothelia Cell-Secreted Exosome Nanovesicles for the Treatment of Brain Cancer.
    Yang T; Fogarty B; LaForge B; Aziz S; Pham T; Lai L; Bai S
    AAPS J; 2017 Mar; 19(2):475-486. PubMed ID: 27882487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.